Optimising Outcomes for Chronic Kidney Disease: The Emerging Treatment Paradigm

Visit https://www.peervoice.com/SXY860 to view the entire programme with slides. After completing “Optimising Outcomes for Chronic Kidney Disease: The Emerging Treatment Paradigm”, participants will be able to: Explain the rationale for SGLT2 inhibition for chronic kidney disease (CKD); Summarise current best practices for managing CKD, including the role of SGLT2 inhibitors; Apply principles of active diagnosis and management of CKD to practice, with the goal of improving outcomes.